Physician profile
Stuart G Goodman
NPI 1154432425
$13,870.26
in general payments reported to CMS, 2019-2025
18 companies · $2,000 in 2025
The $2,000 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,443 · 2020: $712 · 2021: $1,031 · 2022: $3,692 · 2023: $304 · 2024: $2,689 · 2025: $2,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Travel and Lodging: $1,819 · Food and Beverage: $681 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Travel and Lodging | $1,819.26 |
| Food and Beverage | $680.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $492.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,490.52 | 2020-2023 | Eterna |
| Mml US, INC. | $3,029.92 | 2024-2025 | Reactiv8 |
| Nevro Corp. | $2,676.53 | 2019-2023 | Senza |
| Globus Medical, INC. | $1,157.67 | 2019-2022 | |
| Boston Scientific Corporation | $973.60 | 2019-2024 | Vercise |
| Spineology INC. | $492.30 | 2024 | Optimesh Expandable Interbody Fusion System |
| Medtronic, INC. | $405.17 | 2021-2024 | Percept PC Brainsense |
| Medtronic USA, INC. | $249.56 | 2019-2020 | |
| Saluda Medical Americas, INC. | $108.41 | 2023-2024 | Evoke, Evoke Scs |
| Spr Therapeutics, INC | $96.89 | 2019 | |
| Depuy Synthes Sales INC. | $48.42 | 2019 | |
| Abbvie INC. | $30.22 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $26.44 | 2023 | Austedo |
| Axonics, INC. | $23.89 | 2020 | |
| Portola Pharmaceuticals, LLC | $18.66 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $17.37 | 2019 | |
| Monteris Medical Corporation | $16.48 | 2021 | |
| Kls-Martin L.P. | $8.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$495,260.40 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.